What’s Next for Oragenics Inc (NYSEAMERICAN:OGEN) After Having More Shares Shorted?

October 11, 2018 - By Linda Rogers

Oragenics, Inc. (NYSEAMERICAN:OGEN) Logo

The stock of Oragenics Inc (NYSEAMERICAN:OGEN) registered an increase of 13.02% in short interest. OGEN’s total short interest was 877,600 shares in October as published by FINRA. Its up 13.02% from 776,500 shares, reported previously. With 486,200 shares average volume, it will take short sellers 2 days to cover their OGEN’s short positions. The short interest to Oragenics Inc’s float is 10.49%.

The stock increased 12.13% or $0.1262 during the last trading session, reaching $1.1662. About 4.08 million shares traded. Oragenics, Inc. (NYSEAMERICAN:OGEN) has declined 87.39% since October 11, 2017 and is downtrending. It has underperformed by 103.01% the S&P500.

Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. The company has market cap of $34.00 million. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. It currently has negative earnings. The firm is also developing AG013, which is in initiation of Phase II clinical trial for the treatment of oral mucositis in cancer patients.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News